Home / Sell by State / New Jersey
New Jersey · Sell-Side M&A
New Jersey enforces the corporate practice of medicine, and it treats a med spa as a medical practice. That means you never sell the clinical entity outright. You structure a physician-owned PC and an MSO, and a 2017 New Jersey Supreme Court decision sets the rules for getting it right. That structure is exactly where value is won or lost. We represent New Jersey owners only, and we build the deal around the rules instead of around the buyer.
A confidential ballpark in under two minutes, no email required.
New Jersey's Real Differentiator
New Jersey prohibits the corporate practice of medicine. A non-physician, a private equity firm, or a general business corporation cannot own a medical practice or control clinical decisions here. Medical practice ownership is limited to licensed health care professionals, and because the state treats med spa and aesthetic services as the practice of medicine, a med spa is a medical practice under the same rule. That single rule is why a New Jersey sale is never an off-the-shelf company purchase, and why structure decides whether your deal closes and at what price.
The lawful path is a physician-owned professional corporation that keeps the clinical practice, paired with a management services organization that provides non-clinical business services at fair market value. The MSO is what a non-physician buyer actually owns and capitalizes. It handles billing, payroll, HR, marketing, IT, scheduling, and property.
The MSO cannot direct or control clinical decisions, cannot hire, supervise, or fire physicians on clinical grounds, cannot dictate clinical protocols, and cannot split fees or tie compensation to referrals. Those limits are the real driver of how much control a buyer can hold, and they shape the whole deal.
The controlling New Jersey Supreme Court decision sets the do's and don'ts. Majority shares and voting must stay with the plenary licensed physician-owner. The practice pays fair market value for management. No pre-signed undated removal documents, no punitive break fees, and no clause that removes the physician-owner in a conflict between medical judgment and cost.
The New Jersey Board of Medical Examiners enforces the ownership rules under N.J.A.C. Title 13:35, and the practice of medicine is defined broadly by statute at N.J.S.A. 45:9-51 and following. A buyer's counsel will test your structure against all of it before close.
New Jersey enforces a corporate-practice-of-medicine prohibition under the Board of Medical Examiners rules at N.J.A.C. Title 13:35, with the practice of medicine defined at N.J.S.A. 45:9-51 et seq., and the structure rules confirmed by the 2017 New Jersey Supreme Court decision in Allstate Insurance Company v. Northfield Medical Center, P.C. Accurate as of June 2026. Sources: Stevens & Lee, Greenbaum Rowe, Zivian Health, and Faegre Drinker healthcare-law analyses (linked in our sources).
| Metric | Figure | Note |
|---|---|---|
| New Jersey population | ~9.4M | Most densely populated US state |
| State-level med spa count | Not published | AmSpa reports national totals only |
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only and includes no state-by-state breakdown or ranking. Population figure is a US Census Bureau estimate.
Market Reality
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable New Jersey figure. What is verifiable is scale: New Jersey is the most densely populated state in the country at roughly 9.4 million residents, a dense, high-income footprint that is exactly the kind of market national platforms keep buying into.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No New Jersey-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a New Jersey seller's realized value is how the deal has to be built and how cleanly the friendly-PC and MSO structure clears the rules a buyer's counsel will test.
Because value transfers through an MSO and a management agreement rather than direct equity in the clinical PC, a buyer is paying for the management-fee stream and the durability of the PC relationship. A practice with a fair-market-value fee and physician voting control intact transacts faster and holds its multiple.
Map my structure →A management agreement that offends Allstate v. Northfield, with a removal clause, a punitive break fee, or pre-signed removal documents, is a discount or a deal-killer. Buyers scrutinize the MSA, the PC ownership, and the fee before they price the practice.
See the structure rules →New Jersey is a dense aesthetics market, and national platforms are actively consolidating here. A deep buyer pool, national PE platforms plus regional consolidators already in-state, supports competitive tension for a well-prepared seller.
Who is buying →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a New Jersey-specific multiple, because none exists in a citable, defensible form. Your real range comes from a confidential, practice-specific analysis of your earnings, your structure, and your comps.
Who Is Actually Buying in New Jersey
A New Jersey seller does not depend on one local acquirer. Well-capitalized national platforms and PE-backed MSOs buy here, and there is a documented, in-state proof point: Schweiger Dermatology Group acquired the New Jersey practices of NavaDerm Partners, Scherl Dermatology in Englewood Cliffs and Millburn Laser Center in Millburn, announced in December 2023, with nine providers joining. We will never name a "local buyer" that does not exist. Compare every market on the Sell by State directory.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential.
Schweiger / NavaDerm is the in-state proof point, documented in Schweiger's own press release and the LLR Partners portfolio page. Schweiger's office count reflects the 160-plus locations published on its own locations page, and it had earlier expanded in New Jersey through The Derm Group and DermOne. The other platforms are named as national consolidators active in the dermatology and aesthetics vertical, per Practical Dermatology and Physician Growth Partners market context. No local-only buyer is asserted.
New Jersey Sale FAQ
Not the way they would buy a normal business. New Jersey prohibits the corporate practice of medicine, so a non-physician investor or a general business corporation cannot own a medical practice or control clinical decisions. The lawful path is the friendly-PC and MSO structure: a physician-owned professional corporation keeps the clinical practice, and a separate management services organization, the part the investor owns and funds, contracts to provide non-clinical business services at fair market value. New Jersey treats med spa and aesthetic services as the practice of medicine, so a med spa is covered too. That is why a New Jersey sale is a structured transaction, not a simple stock or asset sale.
In New Jersey a buyer does not literally buy and hold the clinical entity. The buyer acquires or builds the MSO and contracts with your physician-owned professional corporation through a management services agreement. The MSO can handle billing, collections, payroll, HR, marketing, IT, scheduling, property, and inventory, but it cannot direct clinical decisions, hire or fire physicians on clinical grounds, dictate clinical protocols, or split fees. This is standard and bankable. It shapes diligence, because the management agreement, the PC ownership, the fair-market-value fee, and the absence of prohibited removal or penalty clauses are all scrutinized.
The 2017 New Jersey Supreme Court decision in Allstate Insurance Company v. Northfield Medical Center, P.C. sets the do’s and don’ts for physician-MSO arrangements. The majority of shares and voting rights must stay with the plenary licensed physician-owner. The medical practice must pay fair market value for management services. The agreement cannot let the management company take all remaining profits, cannot allow removal of the physician-owner in a conflict between medical judgment and cost containment, cannot rely on pre-signed undated removal documents, and cannot use a punitive break fee. A clean structure that respects these limits is what survives a challenge by an insurer or a regulator.
No. There is no published New Jersey-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how New Jersey law and market move structure and value. Because value transfers through an MSO and a management agreement rather than direct equity in the clinical PC, the cleanliness of that structure is a direct value lever. A defensible structure, with a fair-market-value fee, physician voting control intact, and no prohibited removal or penalty terms, protects your value. A non-compliant one invites a discount or a re-trade. Your real number comes from a confidential, practice-specific analysis.
Demand is national and verifiably present in New Jersey. Schweiger Dermatology Group, a private-equity-backed platform, acquired the New Jersey practices of NavaDerm Partners, namely Scherl Dermatology in Englewood Cliffs and Millburn Laser Center in Millburn, announced in December 2023, with nine providers joining. Schweiger operates more than 160 offices across the East Coast, including New Jersey, and had earlier expanded in the state through The Derm Group and DermOne. Other national consolidators active in the broader dermatology and aesthetics vertical include Epiphany Dermatology, Pinnacle Dermatology, and DermCare. The accurate picture is well-capitalized national platforms and PE-backed MSOs buying in New Jersey, not a single local acquirer.
New Jersey is a dense, affluent Northeast aesthetics market. AmSpa’s State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable New Jersey figure. What is verifiable is scale: New Jersey is the most densely populated state in the country, with roughly 9.4 million residents per US Census Bureau estimates, which is the kind of dense, high-income market national consolidators target.
Match Your Practice Type
How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the New Jersey structure work above.
Med spa sell-side →Where New Jersey's documented in-state derm activity is happening, and how a cosmetic derm practice is valued for sale.
Cosmetic derm sell-side →The valuation and deal-structure work for a surgical aesthetic practice, mapped to New Jersey's corporate-practice rules.
Plastic surgery sell-side →
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
